Nectar Lifesciences completes buyback of 3 crore shares at INR 27

Corporate Actions View source PDF Explain this filing

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.3%Reaction day

₹13.94

prior close

₹13.90

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.6%+2.7% vs market

On the reaction day the stock moved 2.7 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.1

10m

+1.2

15m

+2.8

30m

+4.6

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

+4.3+1.6+2.7

Next day

+4.4-0.6+5.1

+0.4-0.5+0.9

+0.1+1.5-1.5

-1.1+1.1-2.3

-2.7+3.0-5.6

-0.3+5.5-5.8

15d

-3.9+6.1-9.9

-8.9+5.1-14.0

-25.3-8.0-17.3

-11.4+10.9-22.3

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nectar Lifesciences has completed extinguishment of 3 crore equity shares bought back at INR 27 per share through tender offer. Paid-up share capital reduced from 22.42 crore to 19.42 crore shares, about 13.4 percent reduction. Tendering period ran from December 31, 2025 to January 6, 2026.

Likely market impact

Share count drops 13.4 percent, can lift EPS. Buyback signals management confidence. Price of INR 27 per share is a value reference.